· HOME    · CONTACT US    · SITE MAP    

About VIMAC

Our Team

Philosophy

Portfolio

Portfolio Overview

VIMAC I.T. II

Life Sciences Fund

View All

For Entrepreneurs


Life Sciences

IT/Adv.Materials





AngioChem


Sector
Life Sciences

Category
Brain Therapy

About
AngioChem is a Montreal-based biotechnology company dedicated to creating and developing novels therapies which traverse the Blood-Brain Barrier to treat diseases of the brain. AngioChem leverages a breakthrough technology capable of transporting any size of molecule to the brain. To validate the potential of this broad-based platform technology, the company will soon be entering clinical development for its lead program targeting brain cancer. AngioChem has also extended the use of its technology to transport monoclonal antibodies to the brain. AngioChem will enter into collaborative research and development programs with biotechnology and pharmaceutical companies whose compounds' therapeutic indices could be greatly enhanced by the Angiochem platform.

AngioChem news

<< back

AngioChem
141 President Kennedy
Suite SB-5210
Montreal, Quebec H2X 3Y7
Canada

www.angiochem.com